Description

BSE announces the listing of 3000 Commercial Papers of Rs. 5,00,000 each issued by 360 ONE WAM LIMITED on private placement basis, effective November 24, 2025.

Summary

BSE has listed new Commercial Papers issued by 360 ONE WAM LIMITED on private placement basis with effect from November 24, 2025. The listing comprises 3000 Commercial Papers with a face value of Rs. 5,00,000 each, totaling Rs. 150 crore. The instruments carry credit ratings of CARE A1+ and ICRA A1+, with a tenure of 91 days from allotment to redemption.

Key Points

  • Quantity: 3000 Commercial Papers
  • Face Value: Rs. 5,00,000 per unit
  • Issue Price: Rs. 4,91,279 per unit
  • Scrip Code: 730625
  • Scrip ID: OWL211125
  • ISIN: INE466L14FG1
  • Credit Rating: CARE A1+, ICRA A1+
  • Market Lot: 1 unit
  • Trading denomination: Rs. 5 lakhs and multiples thereof
  • Tick size: 1 paise
  • Issuing and Paying Agent: HDFC Bank
  • Trading mode: Dematerialized form only

Regulatory Changes

No regulatory changes. This is a standard listing notification.

Compliance Requirements

  • Trading members must trade these securities only in dematerialized form under ISIN INE466L14FG1
  • Trading shall take place in standard denomination of Rs. 5 lakhs and multiples thereof
  • Members requiring clarification may contact the debt department at specified phone numbers (22728352/8597/8995/5753/8915)

Important Dates

  • Allotment Date: November 21, 2025
  • Listing Date: November 24, 2025
  • Redemption Date: February 20, 2026
  • Tenure: 91 days

Impact Assessment

This is a routine commercial paper listing with minimal market impact. The listing provides short-term debt market participants with an additional investment avenue in highly-rated commercial paper from 360 ONE WAM LIMITED. The instruments carry top-tier credit ratings (A1+ from both CARE and ICRA), indicating low credit risk. The listing expands debt market options but has no direct impact on equity markets or broader trading operations.

Impact Justification

Routine commercial paper listing with no broader market implications or regulatory changes